Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Gift or transfer — classified separately from trades.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 19, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 22, 2026
CEOIndirect holdingGift / transfer
Context
Classification
gift transfer
Code G — gift, bequest or transfer
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001493152-26-039746
Filed / recorded
Aug 22, 2026, 2:26 AM UTC
Added to OQRO
Oct 7, 2026, 11:38 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
PALISADE BIO, INC.
Issuer CIK
1357459
Ticker
PALI
Reporting person
John David Finley
Relationship
Director, Officer
Officer title
CEO, CFO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Aug 19, 2026
Transaction code
G
Shares / units
88,400
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
88,451
Ownership form
Indirect — By FCW Investments, LLC
Amendment
No
Footnotes from the filing
The Reporting Person transferred these shares to FCW Investments, LLC. The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.